Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Goodwill: 2010-2024

Historic Goodwill for Ligand Pharmaceuticals (LGND) over the last 13 years, with Dec 2024 value amounting to $105.2 million.

  • Ligand Pharmaceuticals' Goodwill fell 3.52% to $101.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.5 million, marking a year-over-year decrease of 3.52%. This contributed to the annual value of $105.2 million for FY2024, which is 1.82% up from last year.
  • Per Ligand Pharmaceuticals' latest filing, its Goodwill stood at $105.2 million for FY2024, which was up 1.82% from $103.4 million recorded in FY2023.
  • In the past 5 years, Ligand Pharmaceuticals' Goodwill registered a high of $189.7 million during FY2020, and its lowest value of $103.4 million during FY2023.
  • Its 2-year average for Goodwill is $104.3 million, with a median of $104.3 million in 2023.
  • Data for Ligand Pharmaceuticals' Goodwill shows a peak YoY spiked of 99.16% (in 2020) over the last 5 years.
  • Ligand Pharmaceuticals' Goodwill (Yearly) stood at $189.7 million in 2020, then reached $103.4 million in 2023, then rose by 1.82% to $105.2 million in 2024.